• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

ABATACEPT

Immune checkpoint blockade in cancer immunotherapy

August 28, 2018Cancer, Cancer Immunotherapy, Vizit Graphs
Immune checkpoint blockade in cancer immunotherapy

Explore immune checkpoint blockade (PD-1, CTLA-4) in cancer immunotherapy with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

BREAST CANCER SOD1 INFLAMMATION DIABETES MELLITUS LISTERIA MONOCYTOGENES IL23A PSEUDOMONAS AERUGINOSA IL17A AGING METFORMIN FOXP3 CELL DEATH APOPTOTIC PROCESS ERBB-2 RHEUMATOID ARTHRITIS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE TP53 IFNG CELL DIFFERENTIATION CANCER TH17 CELLS AUTOPHAGY INSULIN HELICOBACTER PYLORI PARKINSON DISEASE CASP3 ESCHERICHIA COLI STREPTOCOCCUS PNEUMONIAE CELL DIVISION PORPHYROMONAS GINGIVALIS CELL PROLIFERATION ALZHEIMER'S DISEASE IL6 NEURODEGENERATIVE DISORDERS TNF CLOSTRIDIUM DIFFICILE STAPHYLOCOCCUS AUREUS IMMUNE RESPONSE DOXORUBICIN CANDIDA ALBICANS REMICADE ANGIOGENESIS RECEPTOR CD4 CTLA4

© 2019 Biovista Vizit All Rights Reserved.